WELL's 32.3% year-to-date stock price surge is fueled by its strong senior housing growth and favorable outpatient visit trend, backed by solid liquidity.
PTX Metals Inc. (TSXV: PTX) ("PTX" or the "Company") is pleased to announce the closing of the fourth and final tranche of ...
Rothschild views Agilent as a leading pure play in life science instruments with diverse end markets (only 34% of revenue from Pharma) and an impressive 64% recurring revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback